The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2025

Filed:

Oct. 09, 2023
Applicant:

Neuraxis, Inc., Versailles, IN (US);

Inventors:

Christopher R. Brown, Greensburg, IN (US);

Gary M. Peterson, Versailles, IN (US);

Assignee:

NEURAXIS, INC., Verasilles, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/05 (2005.12); A61N 1/36 (2005.12); A61K 31/485 (2005.12);
U.S. Cl.
CPC ...
A61N 1/0529 (2012.12); A61N 1/0551 (2012.12); A61N 1/36071 (2012.12); A61N 1/36096 (2012.12); A61K 31/485 (2012.12);
Abstract

A method for treating pain or discomfort in a patient is disclosed. The method comprises stimulating a cranial nerve with an electrical signal. The pain or discomfort may be a withdrawal symptom. The cranial nerve may be in an auricular area of the patient. The cranial nerve may be cranial nerve V, cranial nerve VII, cranial nerve IX, cranial nerve X, or branches of greater and lesser occipital nerves thereof and their associated neurovascular bundles. The withdrawal symptom may result from cessation of an opioid. The method may further comprise administering a secondary drug treats one or more of the withdrawal symptoms and addiction. The secondary drug may be administered about one day to about one week after initiating the stimulating step.


Find Patent Forward Citations

Loading…